↓ Skip to main content

Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

Overview of attention for article published in Pulmonary Therapy, June 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#12 of 188)
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
2 news outlets
twitter
13 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
24 Mendeley
Title
Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
Published in
Pulmonary Therapy, June 2018
DOI 10.1007/s41030-018-0057-7
Pubmed ID
Authors

Bernardino Alcázar Navarrete, Isabelle Boucot, Ian Naya, Lee Tombs, David A. Lipson, Chris Compton, Ana R. Sousa, Gregory Feldman

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 17%
Student > Bachelor 4 17%
Student > Ph. D. Student 3 13%
Researcher 3 13%
Student > Master 2 8%
Other 2 8%
Unknown 6 25%
Readers by discipline Count As %
Medicine and Dentistry 5 21%
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Biochemistry, Genetics and Molecular Biology 2 8%
Nursing and Health Professions 2 8%
Agricultural and Biological Sciences 1 4%
Other 2 8%
Unknown 9 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2023.
All research outputs
#1,432,804
of 24,066,486 outputs
Outputs from Pulmonary Therapy
#12
of 188 outputs
Outputs of similar age
#31,465
of 331,939 outputs
Outputs of similar age from Pulmonary Therapy
#3
of 11 outputs
Altmetric has tracked 24,066,486 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 188 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,939 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.